Keyphrases
Endothelial Function
90%
Magnesium
86%
Acute Myocardial Infarction
84%
Patients with Coronary Artery Disease
73%
Flow-mediated Dilation
59%
Acute Coronary Syndrome
55%
Placebo
53%
Magnesium Treatment
43%
Platelets
43%
Myocardial Infarction Patients
42%
Thrombosis
41%
Coronary Patients
40%
ST-elevation Myocardial Infarction (STEMI)
37%
Magnesium Supplementation
35%
Platelet Aggregation
35%
Mg Magnesium
34%
Exercise Tolerance
32%
Israel
31%
Statin Therapy
30%
Cardiovascular Events
29%
Percutaneous Coronary Intervention
28%
Coronary Artery Disease
28%
Serum Magnesium
28%
Heart Disease
26%
Statins
26%
Hypomagnesemia
24%
Acute Decompensated Heart Failure
24%
Thrombolytic Therapy
23%
Clinical Outcomes
23%
Intravenous Magnesium
23%
Myocardial Infarction
22%
Aspirin
21%
Clopidogrel
21%
Brachial Artery
20%
Angina Pectoris
20%
Intracellular Magnesium
18%
Magnesium Sulfate
18%
Magnesium Level
18%
Consensus Document
16%
Stable Coronary Artery Disease
16%
Low-density Lipoprotein Cholesterol (LDL-C)
16%
Endothelial Dysfunction
16%
All-cause Mortality
16%
Heart Failure Patients
16%
Vascular Endothelial Function
16%
Beneficial Effects
16%
Desalinated Seawater
15%
Patients with Cardiovascular Diseases
15%
Heart Failure
15%
Cardiovascular Outcomes
15%
Medicine and Dentistry
Endothelial Function
100%
Magnesium
66%
Heart Failure
63%
Coronary Artery Disease
63%
Cardiovascular System
62%
Brachial Artery
37%
Cardiovascular Disease
33%
Myocardial Infarction
28%
Placebo
25%
Heart Disease
24%
Vasodilatation
23%
Percutaneous Coronary Intervention
23%
Artery Blood Flow
22%
Exercise
21%
Acute Heart Infarction
21%
Acute Coronary Syndrome
19%
ST Segment Elevation Myocardial Infarction
19%
Platelet
19%
Exercise Tolerance
19%
Angina Pectoris
18%
Glyceryl Trinitrate
18%
Thrombosis
18%
Statin
17%
Apoplexy
17%
Infarction
15%
Endothelial Dysfunction
15%
Atherosclerosis
15%
Diabetes Mellitus
14%
Ischemic Heart Disease
14%
Dobutamine
13%
Drug Therapy
13%
Coronary Artery
13%
ST Elevation
12%
Low Drug Dose
12%
Revascularization
12%
Systematic Review
11%
External Counterpulsation
11%
Periodontitis
11%
Emergency Department
11%
Middle Age
11%
Thallium 201
11%
Chest Pain Unit
11%
Laron Syndrome
11%
Heart Transplantation
11%
Stent Thrombosis
11%
Cardiovascular Risk
10%
Hypomagnesemia
10%
Heart Left Ventricle Ejection Fraction
10%
Heart Function
10%
Primary Percutaneous Coronary Intervention
9%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
74%
Acute Heart Infarction
69%
Placebo
59%
Heart Failure
58%
Heart Infarction
45%
Statin (Protein)
37%
Cardiovascular Disease
36%
Acute Coronary Syndrome
27%
ST Segment Elevation Myocardial Infarction
27%
Normal Human
25%
Acetylsalicylic Acid
25%
Glyceryl Trinitrate
25%
Fibrinolytic Agent
23%
Low Density Lipoprotein Cholesterol
22%
Infarction
19%
Heart Disease
19%
Magnesium Sulfate
18%
Angina Pectoris
18%
Clopidogrel
18%
Diabetes Mellitus
17%
Adverse Event
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Endothelial Dysfunction
15%
Thrombosis
15%
Disease
14%
Ischemic Heart Disease
14%
Atherosclerosis
13%
Hypomagnesemia
13%
Periodontitis
11%
Thallium 201
11%
All Cause Mortality
11%
Heart Arrhythmia
10%
Cardiovascular Risk
9%
Adenosine Diphosphate
9%
Nonischemic Cardiomyopathy
9%
Hospital Mortality
9%
Obesity
8%
Dobutamine
8%
Heart Ventricle Fibrillation
7%
Chronic Kidney Failure
7%
Antithrombotic Therapy
7%
Sea Water
7%
Antiplatelet
7%
Magnesium Oxide
7%
Evolocumab
6%
Magnesium Deficiency
6%
Proprotein Convertase 9
6%
Prevalence
6%
Heart Ventricle Tachycardia
6%
Randomized Clinical Trial
6%